In yesterday’s Wall Street session, Theravance Biopharma Inc (NASDAQ:TBPH) shares traded at $8.97, down -0.44% from the previous session.
TBPH stock price is now -0.70% away from the 50-day moving average and -7.77% away from the 200-day moving average. The market capitalization of the company currently stands at $432.00M.
On May 23, 2022, SVB Leerink recently initiated its ‘Outperform’ rating on the stock quoting a target price of $12, while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS sold 1,254 shares of the company’s stock on Feb 22 ’24. The stock was sold for $10,922 at an average price of $8.71. Upon completion of the transaction, the SVP, COMM & MEDICAL AFFAIRS now directly owns 311,733 shares in the company, valued at $2.8 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 21 ’23, SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda sold 1,378 shares of the business’s stock. A total of $14,180 was realized by selling the stock at an average price of $10.29. This leaves the insider owning 331,206 shares of the company worth $2.97 million. A total of 7.85% of the company’s stock is owned by insiders.
During the past 12 months, Theravance Biopharma Inc has had a low of $8.21 and a high of $12.03. As of last week, the company has a debt-to-equity ratio of 0.23, a current ratio of 5.39, and a quick ratio of 5.39. The fifty day moving average price for TBPH is $9.03 and a two-hundred day moving average price translates $9.73 for the stock.
The latest earnings results from Theravance Biopharma Inc (NASDAQ: TBPH) was released for Dec, 2023. According to the Biotechnology Company, earnings per share came in at -$0.17, missing analysts’ expectations of -$0.15 by -0.02. This compares to $0.38 EPS in the same period last year. The net profit margin was -96.12% and return on equity was -16.86% for TBPH. The company reported revenue of $17.57 million for the quarter, compared to $14.65 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 19.91 percent. For the current quarter, analysts expect TBPH to generate $14.92M in revenue.
